Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 371

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 371
---
 Continuous Evolution Kit Starting in the fourth quarter of 2024, customers were provided with the option to purchase independent gut microbiome tests by purchasing the “Continuous Evolution Kit,” that collects stool samples for gut microbiome analysis. These customers will also be able to purchase the “Complete Profile Kit” to obtain more holistic results and health recommendations, by integrating their DNA data with their results. The updated microbiome results allow customers to keep track of their progress and compare with earlier results. In the pilot phase, the telemedicine session focused on reviewing significant results from the report and the progress made, resolving any queries about results, analyzing changes in the intestinal microbiome to make necessary lifestyle adjustments, setting new goals based on these results, and revising unmet goals to align with the customer’s lifestyle for future success. After the updated habit plan is provided, customers can repurchase the “Continuous Evolution Kit” to perpetuate their lifestyle improvement, thus creating a continuous cycle of health improvement. Heritas Diagnostics: Clinical Diagnostics, Prognosis, and Monitoring Heritas Diagnostics offers a comprehensive suite of genetic tests that processes high -qualitygenetic and clinical data, instrumental in enhancing clinical healthcare decisions. The tests are designed to supply precise genetic insights to doctors, patients, and their families for diagnosis, prognosis and monitoring, allowing them to make informed treatment decisions over various conditions. Currently, we offer these services in Argentina and Paraguay. The tests and services are distributed through a business -to -businessmodel, through partnerships with clinical laboratories. These laboratories offer advanced diagnostic services to their customers, which include health system stakeholders, such as patients, providers, government agencies, pharmacies, and/or private health institutions. Patient samples, including blood, tissue biopsies, saliva, plasma or nucleic acids, are collected through these clinical laboratories and processed in our Argentine Wet -Labaccording to the specific analysis required. Our genetic tests are designed for high accuracy in detection and profiling, utilizing sophisticated bioinformatics tools to decipher complex genetic information, and provide a wide array of clinically actionable insights. To support our operations, we have an agreement with a medical geneticist specializing in oncology and clinical genomics who provides counseling and advisory services as needed. Under this agreement, the professional offers genetic counseling, internal support for accurate genetic reporting, participation in medical events to promote our 184 services, guidance for distributors on appropriate genetic tests, communication of results in an accessible manner, and collaboration in developing new services and scientific publications. The scope of services also includes pre- and post -testgen